Why Is 2026 Seeing a Rise in "Precision Medicine" for Eye Inflammation?
Uveitis isn't a "one-size-fits-all" condition, and in early 2026, our treatments are finally reflecting that reality. In early 2026, the Uveitis Treatment Sector is utilizing "biomarker testing" to identify exactly which part of your immune system is overreacting. Instead of trying several different medications to see what works, your doctor can now use a small sample of eye fluid or a blood...
0 Reacties 0 aandelen 28 Views 0 voorbeeld